CUFinder

Raymond Cross

Raymond Cross

University of Maryland, Baltimore

H-index: 43

North America-United States

Contact Raymond Cross

About Raymond Cross

Raymond Cross, With an exceptional h-index of 43 and a recent h-index of 33 (since 2020), a distinguished researcher at University of Maryland, Baltimore, specializes in the field of Inflammatory Bowel Disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

ExpLOring the role of the intestinal MiCrobiome in InflammATory bowel disease-AssocIated SpONdylarthritis (LOCATION-IBD)

Long-Term Effectiveness and Durability of COVID-19 Vaccination among Patients with Inflammatory Bowel Disease

Humoral immune response and safety of SARS‐CoV‐2 vaccination in very early onset inflammatory bowel disease

THE COLONIC MUCOSAL MICROBIOME IN IBD-ASSOCIATED ARTHRITIS IS MORE VARIABLE THAN IN IBD ALONE

BIOLOGICS AND SMALL MOLECULES USED IN IBD MIMICS: HIGHLIGHTING THE IMPORTANCE OF DIAGNOSIS CONFIRMATION

Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases

Yield of Serial Testing for Tuberculosis Exposure in Patients With Inflammatory Bowel Diseases: One Test is Not Enough

P1017 Upadacitinib as rescue therapy for the treatment of Acute Severe Colitis in an acute care setting

Raymond Cross Information

University

Position

School of Medicine

Citations(all)

6053

Citations(since 2020)

3701

Cited By

3604

hIndex(all)

43

hIndex(since 2020)

33

i10Index(all)

103

i10Index(since 2020)

88

Email

University Profile Page

Google Scholar

Raymond Cross Skills & Research Interests

Inflammatory Bowel Disease

Top articles of Raymond Cross

ExpLOring the role of the intestinal MiCrobiome in InflammATory bowel disease-AssocIated SpONdylarthritis (LOCATION-IBD)

Heliyon

2024/2/18

Jacques Ravel
Jacques Ravel

H-Index: 70

Long-Term Effectiveness and Durability of COVID-19 Vaccination among Patients with Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology

2024/2/17

Xian Zhang
Xian Zhang

H-Index: 3

Jeremy Adler
Jeremy Adler

H-Index: 19

Runa Watkins
Runa Watkins

H-Index: 4

Xiangfeng Dai
Xiangfeng Dai

H-Index: 8

Wenli Chen
Wenli Chen

H-Index: 20

Humoral immune response and safety of SARS‐CoV‐2 vaccination in very early onset inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition

2024/2/14

Xian Zhang
Xian Zhang

H-Index: 3

Jeremy Adler
Jeremy Adler

H-Index: 19

Runa Watkins
Runa Watkins

H-Index: 4

Ryan Ungaro
Ryan Ungaro

H-Index: 23

THE COLONIC MUCOSAL MICROBIOME IN IBD-ASSOCIATED ARTHRITIS IS MORE VARIABLE THAN IN IBD ALONE

Gastroenterology

2024/2/1

Erik Von Rosenvinge
Erik Von Rosenvinge

H-Index: 17

Jacques Ravel
Jacques Ravel

H-Index: 70

Raymond Cross
Raymond Cross

H-Index: 28

BIOLOGICS AND SMALL MOLECULES USED IN IBD MIMICS: HIGHLIGHTING THE IMPORTANCE OF DIAGNOSIS CONFIRMATION

Inflammatory Bowel Diseases

2024/2/1

Christopher Ward
Christopher Ward

H-Index: 19

Raymond Cross
Raymond Cross

H-Index: 28

Andrew Watson
Andrew Watson

H-Index: 44

Badr Al-Bawardy
Badr Al-Bawardy

H-Index: 11

Benjamin Cohen
Benjamin Cohen

H-Index: 2

Jonah Rubin
Jonah Rubin

H-Index: 4

Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases

2024/2

Yield of Serial Testing for Tuberculosis Exposure in Patients With Inflammatory Bowel Diseases: One Test is Not Enough

Clinical Gastroenterology and Hepatology

2024/2/1

Joel Pekow
Joel Pekow

H-Index: 24

Raymond Cross
Raymond Cross

H-Index: 28

Richard Duerr
Richard Duerr

H-Index: 39

Sumona Saha
Sumona Saha

H-Index: 13

P1017 Upadacitinib as rescue therapy for the treatment of Acute Severe Colitis in an acute care setting

Journal of Crohn's and Colitis

2024/1/1

L George
L George

H-Index: 10

DOP16 Safety of long-term ozanimod treatment for up to 4 years in patients with moderately to severely active Ulcerative Colitis: an interim analysis of the True North open …

Journal of Crohn's and Colitis

2024/1/1

DOP64 Steroid-sparing effect of risankizumab vs ustekinumab in patients with moderately to severely active Crohn’s Disease: Post hoc results from the phase 3b SEQUENCE trial

Journal of Crohn's and Colitis

2024/1/1

X Gao
X Gao

H-Index: 8

Cardiovascular safety of ozanimod in patients with ulcerative colitis: true north and open-label extension analyses

Clinical Gastroenterology and Hepatology

2023/11/30

Alessandro Armuzzi
Alessandro Armuzzi

H-Index: 39

Jason Hou
Jason Hou

H-Index: 7

Anjali Jain
Anjali Jain

H-Index: 4

Clinical Decision Making in IBD Mimics: Practice Management from IBD LIVE

Crohn's & Colitis 360

2024/4/11

Christopher Ward
Christopher Ward

H-Index: 19

Badr Al-Bawardy
Badr Al-Bawardy

H-Index: 11

Andrew Watson
Andrew Watson

H-Index: 44

Correlation Between Serum and Fecal Biomarkers and Patient-Reported Outcomes in Patients with Crohn’s Disease and Ulcerative Colitis

Digestive Diseases and Sciences

2024/4/5

Cardiovascular Comorbidities and Inflammatory Bowel Disease: Causes and Consequences

Gastroenterology & Hepatology

2024/4

Preetika Sinh
Preetika Sinh

H-Index: 10

Cystoid macular edema after initiation of ozanimod for ulcerative colitis

Official journal of the American College of Gastroenterology| ACG

2024/3/1

Unravelling the Oral-Gut Axis: Interconnection Between Periodontitis and Inflammatory Bowel Disease, Current Challenges, and Future Perspective

JOURNAL OF CROHNS & COLITIS

2024/2/28

Mario Aimetti
Mario Aimetti

H-Index: 22

Upadacitinib as Rescue Therapy for the Treatment of Acute Severe Colitis in an Acute Care Setting

Digestive Diseases and Sciences

2024/2/28

Unraveling the Oral-Gut axis: Interconnection between Periodontitis and IBD, Current Challenges, and Future Perspective

2024/2/28

Mario Aimetti
Mario Aimetti

H-Index: 22

S876 Etrasimod Demonstrated Consistent Efficacy and Safety as a Monotherapy or With Concomitant Use of Corticosteroids and/or 5-Aminosalicylates: Results From the ELEVATE UC …

Official journal of the American College of Gastroenterology| ACG

2023/10/1

S894 Effects of Early Mucosal Healing at Week 10 Using Stringent Criteria in Patients With Ulcerative Colitis Treated With Ozanimod on Clinical Outcomes at Week 52

Official journal of the American College of Gastroenterology| ACG

2023/10/1

Anjali Jain
Anjali Jain

H-Index: 4

Randy Longman
Randy Longman

H-Index: 20

See List of Professors in Raymond Cross University(University of Maryland, Baltimore)